×

TARGET PEPTIDES FOR IMMUNOTHERAPY AND DIAGNOSTICS

  • US 20150224182A1
  • Filed: 09/03/2013
  • Published: 08/13/2015
  • Est. Priority Date: 08/31/2012
  • Status: Active Grant
First Claim
Patent Images

1. A composition comprising at least or about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more synthetic target peptides, each of which is at least or about 8, 9, 10, 11, 12, 13, 14, or 15 amino acids long, comprising:

  • a first peptide comprising a sequence selected from the group consisting of SEQ ID NO;

    398, SEQ ID NO;

    2000, SEQ ID NO;

    2001, and SEQ ID NO;

    2002; and

    /ora second peptide comprising a sequence selected from the group consisting of SEQ ID NO;

    418, SEQ ID NO;

    2062, and SEQ ID NO;

    2063; and

    /oran optional third peptide comprising a sequence selected from the group consisting of SEQ ID NO;

    427;

    SEQ ID NO;

    2078, SEQ ID NO;

    2079, SEQ ID NO;

    2080, SEQ ID NO;

    2081, SEQ ID NO;

    2082, SEQ ID NO;

    2083, and SEQ ID NO;

    2084; and

    /oran optional fourth peptide selected from the group consisting of GLLGpSPVRA (SEQ ID NO;

    396; and

    SEQ ID NO;

    1996; and

    /oran optional fifth peptide from the group consisting of VMIGsPKKV (SEQ ID NO;

         426) and (SEQ ID NO;

         2077);

    wherein said composition has the ability to stimulate an T cell mediated immune response to said first, second and/or third peptides; and

    optionally wherein the composition is capable of eliciting a memory T cell response to said first, second and/or third peptides.

View all claims
  • 7 Assignments
Timeline View
Assignment View
    ×
    ×